SPECTRUM PHARMACEUTICALS INC's ticker is and the CUSIP is 84763AAB4. A total of 14 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $744,000 | -87.3% | 400,000 | -90.6% | 0.01% | -86.4% |
| Q3 2017 | $5,861,000 | -39.5% | 4,269,000 | -53.2% | 0.09% | -44.7% |
| Q2 2017 | $9,693,000 | -24.1% | 9,119,000 | -27.7% | 0.16% | -14.5% |
| Q1 2017 | $12,777,000 | +37.8% | 12,619,000 | +22.3% | 0.19% | +34.8% |
| Q4 2016 | $9,271,000 | +31.1% | 10,319,000 | +32.0% | 0.14% | +50.0% |
| Q3 2016 | $7,070,000 | -4.9% | 7,819,000 | -3.6% | 0.09% | -31.3% |
| Q2 2016 | $7,431,000 | +4.3% | 8,113,000 | +1.6% | 0.13% | +4.7% |
| Q1 2016 | $7,124,000 | +226.6% | 7,985,000 | +223.3% | 0.13% | +341.4% |
| Q4 2015 | $2,181,000 | -12.4% | 2,470,000 | -10.5% | 0.03% | -12.1% |
| Q3 2015 | $2,489,000 | +5.6% | 2,760,000 | +10.4% | 0.03% | +22.2% |
| Q2 2015 | $2,357,000 | +71.2% | 2,500,000 | +66.7% | 0.03% | +80.0% |
| Q1 2015 | $1,377,000 | – | 1,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,860,000 | $18,214,279,000 | 2.93% |
| CSS LLC/IL | 6,925,000 | $12,923,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 13,689,000 | $25,521,000 | 0.46% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,503,000 | $2,776,000 | 0.43% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,519,000 | $4,674,000 | 0.05% |
| OAKTREE CAPITAL MANAGEMENT LP | 400,000 | $744,000 | 0.01% |
| CREDIT SUISSE AG/ | 1,000,000 | $1,856,000 | 0.00% |
| ROYAL BANK OF CANADA | 15,000 | $27,000 | 0.00% |
| SEI INVESTMENTS CO | 23,000 | $43,000 | 0.00% |